Open AccessCapecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?
Author(s) -
Julien Edeline,
David Malka
Publication year - 2022
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.22.01213
Subject(s) - capecitabine , medicine , biliary tract cancer , adjuvant , biliary tract , oncology , cancer , colorectal cancer , gemcitabine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom